- Home
- NMT vs CBUS Comparison
NMT vs CBUS Comparison
Compare NMT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMT | CBUS |
|---|---|---|
| Founded | 1993 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8M | 121.1M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | NMT | CBUS |
|---|---|---|
| Price | $12.96 | $1.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 20.6K | ★ 602.3K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 3.21% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | N/A | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.11 | $1.09 |
| 52 Week High | $13.70 | $4.19 |
Technical Indicators
Market Signals| Indicator | NMT | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 71.95 | 44.39 |
| Support Level | $11.39 | $1.43 |
| Resistance Level | $13.13 | $1.82 |
| Average True Range (ATR) | 0.31 | 0.12 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 47.68 | 83.82 |
Price Performance
Historical ComparisonAbout NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.